Our Cardiovascular Trials
The study is examining if lowering Lipoprotein (a), a type of cholesterol, can reduce the risk of cardiovascular events. If you have known cardiovascular disease or are at risk of cardiovascular disease (including a family history), you might be eligible for this 4-year study.
This study is being conducted at our at our Western Sydney, Central Coast, Canberra, and Brisbane sites.
Apply NowResearch study investigating a new cholesterol medication on reducing cardiovascular events in individuals living with, or at risk of cardiovascular disease.
This study is being conducted at our Canberra site.
Apply NowParatus Clinical is proud to be a Society for Clinical Research Sites member. We actively participate in discussions and decisions that ultimately impact the industry at large. Being a part of the SCRS community gives us the opportunity to be heard and allows us to partake in industry training and events.
T: 1300 742 326